Cellzome AG

14 articles about Cellzome AG

• GlaxoSmithKline to Fully Buy Cellzome AG for $99 Million

  5/15/2012

• Cellzome AG Founder Wins EU Women Innovators Award

  12/6/2011

• Cellzome AG Awarded UK's Technology Strategy Board Grant as Part of the Regenerative Medicine Program

  12/6/2011

• Cellzome AG Proteomic Study Published in the Journal Nature Paves the Way for New Treatment for Incurable Leukaemia Using an Epigenetic Inhibitor

  10/3/2011

• Cellzome AG Achieves Clinical Candidate Milestone from Inflammation Alliance with GlaxoSmithKline

  9/14/2011

• Cellzome AG to Study Epigenetic Factors with Neusentis

  5/10/2011

• Cellzome AG Builds Scientific Advisory Board with World-Leading Experts in Proteomics, Epigenetics and Immunology

  2/23/2011

• Cellzome AG Announces Achievement of Second Milestone in Epigenetics Collaboration with GlaxoSmithKline

  2/8/2011

• Asterand plc’s Subsidiary BioSeek Signs Agreement with Cellzome AG

  9/23/2010

• Cellzome AG Technology Used to Unravel Novel Regulatory Mechanism in Cancer Signaling Pathway

  9/17/2009

• Cellzome AG: Powerful 'Finger-Printing' Technology Identifies Novel Targets For Gleevec(R)

  8/27/2007

• Cellzome AG Receives First Milestone Payment for Alzheimer's Program from Ortho-McNeil Pharmaceutical, Inc.

  3/13/2007

• Cellzome AG Announces Further Extension Of Molecular Pathway Collaboration

  10/25/2006

• Galapagos Genomics NV And Cellzome AG In Kinase Drug Discovery Collaboration

  7/19/2006